Trial intelligence / Profile preview

Pregabalin crossover polysomnography study for sleep maintenance in fibromyalgia

2009-011014-17Phase 3Completed

Sponsor
Pfizer
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of pregabalin in fibromyalgia (FM) (2 arms), sponsored by Pfizer. Primary endpoint: Mean wake after sleep onset. Started May 2009; status: completed.

02

Drugs

pregabalin
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on 2009-011014-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011014-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call